News | MicroTransponder

top of page

News

News stories and press releases are listed below.

If you are a member of the press and require additional information, please contact us directly.

The views and opinions of the media, health care professionals, patients and caregivers may not accurately represent the Vivistim System's FDA approved indication. For more information, please review the Vivistim Manuals, Instructions for Use and Safety Information.

Questions?

Vivistim Co-Founder Named Innovator of the Year by the Congress of Neurological Surgeons featuring MicroTransponder

MedTech Innovator

10/16/25

Long-Term Outcomes of Vagus Nerve Stimulation Paired With Upper Extremity Rehabilitation After Stroke

Stroke

05/07/25

MicroTransponder Raises USD 65M in Series F Financing Round

Medical Buyer

03/12/25

MicroTransponder Receives $65M to Advance Stroke Care with Vivistim

Medical Device Network

03/12/25

MicroTransponder secures US$65 Million Financing Round to Boost Adoption of Vivistim Stroke Therapy

NeuroNews

03/12/25

MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery

Yahoo Finance

03/12/25

MicroTransponder Raises $65M for Nerve Stim Tech

MassDevice

03/12/25

Transforming lives of stroke survivors: AdventHealth, Orlando Neurosurgery first in nation to perform 50 Vivistim implant cases

Advent Health

03/12/25

Vivistim Registry for Paired VNS Therapy (GRASP).

NIH

06/17/24

Coverage Memo

BC/BS Anthem

04/10/24

Coverage Memo

United Healthcare

01/01/24

Coverage Memo: Vagus Nerve Stimulation (VNS)

CIGNA Coverage

04/01/24

Centers for Medicare & Medicaid Services’ (CMS’) Healthcare Common Procedure Coding System (HCPCS) Level II Final Coding, Benefit Category and Payment Determinations

CMS 2023 Reimbursement

04/01/24

Mobile Rehabilitation Services

NeuroAxis

02/28/24

Vivistim Paired VNS System for Stroke Rehabilitation

Hayes Symplr Insurance

02/15/24

Board Certified Neurosurgeon CAST Certified Neuroendovascular Surgeon

Dr. Michael Horowitz

01/11/24

TIME Picks MicroTransponder's Vivistim Paired VNS System for 2023 Best Inventions List in Medical Care Category

Yahoo Finance

10/24/23

Improving Stroke Recovery - 2023 TIME Best Inventions Award

Time Magazine

10/24/23

The Best Inventions of 2023: Improving Stroke Recovery MicroTransponder Vivistim Paired VNS System

MedTech Innovator

10/24/23

MedTech Innovator Crowns MicroTransponder and Mirai Medical Among its Top Innovators of 2023

MedTech Innovator

11/17/23

Neuro-micro-Transponders for a minimally-invasive peripheral nerve interface

SBIR•STTR

08/01/23

Fiscal Year 2024 Medicare Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System Final Rule Summary

HFMA CMS Policy

08/01/23

MicroTransponder Secures CMS Transitional Pass-Through Status & New Technology Add-On Payment for Its Breakthrough Stroke Rehabilitation System, Vivistim

BioSpace

01/31/23

US Venture Parters Microtransponder portal

US Venture Partners

06/20/22

Houlihan Lokey Advises MicroTransponder

Houlihan Lokey

06/20/22

X0HQ3R8, Implantation of Paired Vagus Nerve Stimulator, Using an External Controller:.

ACDIS

10/20/22

New technology is bringing hope and healing to stroke patients at Rancho Los Amigos National Rehabilitation Center

County of Los Angeles

07/14/22

MicroTransponder grabs macro funding round with $73M for stroke rehab neurostimulator

FierceBiotech

09/22/22

MicroTransponder Closes $73M in Series E Financing

Finsmem

09/21/22

Big news for Microtransponder with new CEO and $53M series E

BioWorld

06/21/22

MicroTransponder reports first commercial implantation of its stroke rehab neurostim system

MassDevice

05/20/22

MicroTransponder Raises $53M, Names New CEO

Orthopedic Device & Tech

06/20/22

Can Vagus Nerve Stimulation Treat Stroke?

MDDI

12/23/21

MicroTransponder receives best new product award for Vivistim system

NeuroNews

12/07/21

Vagus Nerve Stimulation System Approved for Post Stroke Rehabilitation Therapy

eMPR

08/27/21

FDA approves first vagus nerve stimulation implant for stroke rehabilitation

FierceBiotech

08/27/21

FDA approves MicroTransponder’s stroke rehab neurostim system

MassDevice

08/27/21

MicroTransponder’s Vivistim Paired VNS system received FDA approval under the premarket approval pathway in August 2021.

Medical Device Network

10/12/21

FDA approves first nerve-stimulation device to aid stroke recovery

Medical Xpress

08/27/21

Novel Stroke Rehab Treatment Wins FDA Approval

MedPage Today

08/27/21

Phase III Update

FDA

09/10/21

What Is Vivistim: The Future of Stroke Treatment

Health Canada Insurdinary

09/14/21

Results of study could be biggest rehab advance in decades for patients after stroke

EurkAlert

04/26/21

Neurostimulation may help restore arm function years after stroke

Medical Design & Outsourcing

04/26/21

FDA grants approval to MicroTransponder rehabilitation system for stroke

Medical Device Network

08/30/21

Do You Have arm Weakness?

Weill Cornell Medical Center

06/26/18

Stroke Rehab Study Uses Neurostimulation To 'Rewire' Brain, Improve Recovery

Ohio State Wexner Medical

05/02/18

New Therapy Rewires the Brain to Improve Stroke Recovery

DAIC

05/09/18

New Technology ‘Rewires’ Brain to Help Stroke Patients Regain Use of Their Arms

Healthline

05/20/18

Neurostimulation implant helps stroke patients recover faster

Slash Gear

05/14/18

Implant Fights Stroke, Tinnitus by Retraining the Brain Microtransponder’s vagus nerve stimulator uses precisely-timed jolts to help stroke victims relearn movements more quickly

IEEE Spectrum

06/10/15

MicroTransponder Announces Positive Medicare Payment Change for Vivistim® Procedure

PR Newswire

11/25/25

MicroTransponder Appoints Dana G. Mead, Jr. as Chair of the Board and Adds Cynthia Lucchese as Independent Director

PR Newswire

11/17/25

Vivistim Co-Founder Named Innovator of the Year by the Congress of Neurological Surgeons

PR Newswire

10/16/25

Connecticut Passes Law to Establish $2 Million Center of Excellence to Provide Veterans with Access to FDA-Approved Vivistim Therapy for Stroke Recovery

PR Newswire

06/16/25

Chronic Stroke Survivors Demonstrate Long-Term Improvement in Motor Impairment with Vivistim Therapy

PR Newswire

05/07/25

MicroTransponder Secures $65 Million to Enhance Vivistim Adoption for Chronic Stroke Recovery

PR Newswire

03/12/25

TIME Picks MicroTransponder's Vivistim Paired VNS System for 2023 Best Inventions List in Medical Care Category

PR Newswire

10/24/23

MicroTransponder Wins Edison Award for The Vivistim Paired VNS System,

A Game-Changer for Stroke Survivors

PR Newswire

04/25/23

First Commercial Vivistim Patient Set to Begin Paired VNS Therapy for Improved Upper Limb Function Post Stroke

PR Newswire

05/11/22

Occupational and Physical Therapists See Promise in New Paired VNS Therapy for Stroke Recovery

PR Newswire

03/01/22

Vivistim Paired VNS System Awarded Gold Electrode Award for Best New Product by Neurotech Reports

PR Newswire

12/07/21

FDA approves ‘first of its kind’ vagus nerve stroke rehab technology

PR Newswire

08/30/21

FDA Approves Stroke Rehabilitation Therapy Created at UT Dallas

PR Newswire

09/10/21

MicroTransponder® Receives FDA Approval for Breakthrough Device Benefiting Stroke Survivors

PR Newswire

08/31/21

FDA greenlights first VNS-based stroke rehabilitation system

PR Newswire

08/27/21

MicroTransponder developing neurostimulation technology to allow tinnitus and stroke victims to re-train their brains

PR Newswire

12/31/15

News1Anchor

Awards

MicroTransponder's Vivistim System has been recognized as a ground breaking innovation.

©2023 TIME USA LLC.
All rights reserved. Used under license.

Sponsorship Partners

MicroTransponder proudly supports the following organizations dedicated helping stroke survivors and their caregivers.

bottom of page